BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
27.20
+0.70 (2.64%)
At close: Sep 11, 2026

BioVersys AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
160143--
Market Cap Growth
-14.69%---
Enterprise Value
11269--
Last Close Price
27.2024.40--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PS Ratio
34.5144.94--
PB Ratio
3.562.39--
P/TBV Ratio
3.572.39--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
24.3121.69--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.500.361.591.86
Net Debt / Equity Ratio
-1.05-1.02-1.46-1.45
Net Debt / EBITDA Ratio
1.883.060.840.71
Net Debt / FCF Ratio
1.842.741.001.06
Asset Turnover
0.050.050.04-
Quick Ratio
7.179.553.513.25
Current Ratio
7.8610.103.563.59
Return on Equity (ROE)
-46.05%-61.93%-194.40%-
Return on Assets (ROA)
-18.32%-19.87%-33.86%-
Return on Capital Employed (ROCE)
-37.40%-24.40%-74.00%-71.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-16.55%-15.30%--
FCF Yield
-16.08%-15.53%--
Buyback Yield / Dilution
-31.25%-68.49%-11.60%-